Atypical patterns of response to immune checkpoint inhibitors: interpreting pseudoprogression and hyperprogression in decision making for patients' treatment

被引：32
作者：
Onesti, Concetta Elisa [1 ,2 ,3 ]
Freres, Pierre [2 ]
Jerusalem, Guy [2 ,3 ]
机构：
[1] Univ Liege, GIGA Res Inst, Lab Human Genet, Liege, Belgium
[2] CHU Liege, Univ Hosp, Dept Med Oncol, Ave Hop 1, B-4000 Liege, Belgium
[3] Univ Liege, GIGA Res Inst, Lab Med Oncol, Liege, Belgium
来源：
JOURNAL OF THORACIC DISEASE | 2019年 / 11卷 / 01期
关键词：
IPILIMUMAB; NIVOLUMAB; DOCETAXEL;
D O I：
10.21037/jtd.2018.12.47
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：35 / 38
页数：4
相关论文
共 50 条
  • [21] Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive
    Ghate, Sameer
    Ionescu-Ittu, Raluca
    Burne, Rebecca
    Ndife, Briana
    Laliberte, Francois
    Nakasato, Antonio
    Duh, Mei Sheng
    MELANOMA RESEARCH, 2019, 29 (03) : 301 - 310
  • [22] Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer
    Colle, Raphael
    Radzik, Anna
    Cohen, Romain
    Pellat, Anna
    Lopez-Tabada, Daniel
    Cachanado, Marine
    Duval, Alex
    Svrcek, Magali
    Menu, Yves
    Andre, Thierry
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 9 - 16
  • [23] Recent advances, patient selection & challenges in managing cancer patients undergoing treatment with immune checkpoint inhibitors
    Rapoport, Bernardo Leon
    Anderson, Ronald
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 155 (02) : 219 - 224
  • [24] Incidence of Thyroid Function Test Abnormalities in Patients Receiving Immune-Checkpoint Inhibitors for Cancer Treatment
    Patel, Nisha Subhash
    Oury, Anais
    Daniels, Gregory A.
    Bazhenova, Lyudmila
    Patel, Sandip Pravin
    ONCOLOGIST, 2018, 23 (10) : 1236 - 1241
  • [25] Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective Study
    Wiens, Lisa
    Schaeffeler, Norbert
    Eigentler, Thomas
    Garbe, Claus
    Forschner, Andrea
    CANCERS, 2021, 13 (11)
  • [26] Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer
    Greally, Megan
    Chou, Joanne F.
    Chatila, Walid K.
    Margolis, Matthew
    Capanu, Marinela
    Hechtman, Jaclyn F.
    Tuvy, Yaelle
    Kundra, Ritika
    Daian, Foysal
    Ladanyi, Marc
    Kelsen, David P.
    Ilson, David H.
    Berger, Michael F.
    Tang, Laura H.
    Solit, David B.
    Diaz, Luis A., Jr.
    Schultz, Nikolaus
    Janjigian, Yelena Y.
    Ku, Geoffrey Y.
    CLINICAL CANCER RESEARCH, 2019, 25 (20) : 6160 - 6169
  • [27] Overall survival benefit of continuing immune checkpoint inhibitors treatment post dissociated response in patients with advanced lung cancer
    Zhou, Huijie
    Sun, Yu
    Xiu, Weigang
    Han, Jialong
    Zhong, Lili
    Suo, Jiaojiao
    Wei, Hao
    Wang, Yan
    Zhu, Jiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (11) : 2979 - 2988
  • [28] Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors
    Kottschade, Lisa A.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (03)
  • [29] Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis
    Galligan, Anna
    Iravani, Amir
    Lasocki, Arian
    Wallace, Roslyn
    Weppler, Alison M.
    Sachithanandan, Nirupa
    Chiang, Cherie
    Colman, Peter G.
    Wentworth, John
    Spain, Lavinia
    Au-Yeung, George
    Lee, Belinda
    Kay, Thomas W. H.
    Hicks, Rodney J.
    Sandhu, Shahneen
    Krishnamurthy, Balasubramanian
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [30] Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease
    Liu, Michael
    Christ, Lisa
    Richters, Anke
    Ozdemir, Berna C.
    ONCOLOGY LETTERS, 2023, 26 (03)
12345